These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 20634941)

  • 21. The clinical use of colistin in patients with cystic fibrosis.
    Beringer P
    Curr Opin Pulm Med; 2001 Nov; 7(6):434-40. PubMed ID: 11706322
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adaptive resistance to tobramycin in Pseudomonas aeruginosa lung infection in cystic fibrosis.
    Barclay ML; Begg EJ; Chambers ST; Thornley PE; Pattemore PK; Grimwood K
    J Antimicrob Chemother; 1996 Jun; 37(6):1155-64. PubMed ID: 8836818
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutations in genes
    Ghassani A; Triponney P; Bour M; Plésiat P; Jeannot K;
    Antimicrob Agents Chemother; 2024 Jan; 68(1):e0129823. PubMed ID: 38092672
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aerosolized antibiotics in cystic fibrosis: an update.
    Fiel SB
    Expert Rev Respir Med; 2014 Jun; 8(3):305-14. PubMed ID: 24838090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TOBI Podhaler for cystic fibrosis patients with Pseudomonas aeruginosa.
    Farinde A
    Nurse Pract; 2015 Jul; 40(7):16-7. PubMed ID: 26080292
    [No Abstract]   [Full Text] [Related]  

  • 26. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis.
    Hazinski TA
    J Pediatr; 1999 Jul; 135(1):130. PubMed ID: 10428654
    [No Abstract]   [Full Text] [Related]  

  • 27. Efficacy of antibiotic combinations in an experimental sepsis model with Pseudomonas aeruginosa.
    Aktas Z; Sonmez N; Oksuz L; Boral O; Issever H; Oncul O
    Braz J Microbiol; 2023 Dec; 54(4):2817-2826. PubMed ID: 37828396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Anti-Pseudomonas aerosol therapy in cystic fibrosis: improvement with tobramycin].
    Foucaud P; Borel B; Charara O; Nathanson S; Petitprez P; Pin I
    Rev Pneumol Clin; 2002 Jun; 58(3 Pt 1):131-8. PubMed ID: 12486796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early Pseudomonas aeruginosa colonisation in cystic fibrosis patients.
    Marchetti F; Candusso M; Faraguna D; Assael BM
    Lancet; 2002 Feb; 359(9306):626-7. PubMed ID: 11867141
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of chronic intermittent administration of inhaled tobramycin on respiratory microbial flora in patients with cystic fibrosis.
    Burns JL; Van Dalfsen JM; Shawar RM; Otto KL; Garber RL; Quan JM; Montgomery AB; Albers GM; Ramsey BW; Smith AL
    J Infect Dis; 1999 May; 179(5):1190-6. PubMed ID: 10191222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Failed Eradication Therapy of New-Onset Pseudomonas aeruginosa Infections in Children With Cystic Fibrosis Is Associated With Bacterial Resistance to Neutrophil Functions.
    Kwong K; Benedetti A; Yau Y; Waters V; Nguyen D
    J Infect Dis; 2022 Jun; 225(11):1886-1895. PubMed ID: 33606875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients.
    Cantón R; Cobos N; de Gracia J; Baquero F; Honorato J; Gartner S; Alvarez A; Salcedo A; Oliver A; García-Quetglas E;
    Clin Microbiol Infect; 2005 Sep; 11(9):690-703. PubMed ID: 16104983
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synergistic activities of ceftazidime-avibactam in combination with different antibiotics against colistin-nonsusceptible clinical strains of
    Mataraci Kara E; Yilmaz M; İstanbullu Tosun A; Özbek Çelik B
    Infect Dis (Lond); 2020 Sep; 52(9):616-624. PubMed ID: 32427010
    [No Abstract]   [Full Text] [Related]  

  • 34. Activity of Antibiotics against Pseudomonas aeruginosa in an
    Diaz Iglesias Y; Van Bambeke F
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015047
    [No Abstract]   [Full Text] [Related]  

  • 35. Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis.
    Ryan G; Jahnke N; Remmington T
    Cochrane Database Syst Rev; 2012 Dec; 12():CD008319. PubMed ID: 23235659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tobramycin for inhalation in cystic fibrosis: Beyond respiratory improvements.
    Chuchalin A; Amelina E; Bianco F
    Pulm Pharmacol Ther; 2009 Dec; 22(6):526-32. PubMed ID: 19616111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ease of use of tobramycin inhalation powder compared with nebulized tobramycin and colistimethate sodium: a crossover study in cystic fibrosis patients with pulmonary Pseudomonas aeruginosa infection.
    Greenwood J; Schwarz C; Sommerwerck U; Nash EF; Tamm M; Cao W; Mastoridis P; Debonnett L; Hamed K
    Ther Adv Respir Dis; 2017 Jul; 11(7):249-260. PubMed ID: 28614995
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A network meta-analysis of the efficacy of inhaled antibiotics for chronic Pseudomonas infections in cystic fibrosis.
    Littlewood KJ; Higashi K; Jansen JP; Capkun-Niggli G; Balp MM; Doering G; Tiddens HA; Angyalosi G
    J Cyst Fibros; 2012 Sep; 11(5):419-26. PubMed ID: 22717535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro activities of various antibiotics, alone and in combination with colistin methanesulfonate, against Pseudomonas aeruginosa strains isolated from cystic fibrosis patients.
    Güzel CB; Gerçeker AA
    Chemotherapy; 2008; 54(2):147-51. PubMed ID: 18322363
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New clinical evidence from the European tobramycin trial in cystic fibrosis.
    Hodson ME; Gallagher CG
    J Cyst Fibros; 2002 Dec; 1(Suppl 2):199-202. PubMed ID: 15463835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.